In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.

In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.

Item
http://www.wikidata.org/entity/Q39863868
Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancersCCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinomaC/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction.Intracellular signaling and hepatocellular carcinoma.The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.Identification of CDK2 as a novel target in treatment of prostate cancer.
P2860

In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.

Item
http://www.wikidata.org/entity/Q39863868
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
In prostate cancer C/EBPalpha ...... E2F and by activation of AKT.
@en
In prostate cancer C/EBPalpha ...... E2F and by activation of AKT.
@nl
type
label
In prostate cancer C/EBPalpha ...... E2F and by activation of AKT.
@en
In prostate cancer C/EBPalpha ...... E2F and by activation of AKT.
@nl
prefLabel
In prostate cancer C/EBPalpha ...... E2F and by activation of AKT.
@en
In prostate cancer C/EBPalpha ...... E2F and by activation of AKT.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
In prostate cancer C/EBPalpha ...... E2F and by activation of AKT.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698